Skip to main content
Normal View

Dáil Éireann debate -
Thursday, 21 Mar 2002

Vol. 550 No. 5

Written Answers. - Drugs Payment Scheme.

Jimmy Deenihan

Question:

115 Mr. Deenihan asked the Minister for Health and Children if he will allow a drug (details supplied) to be available under the drugs payment scheme; and if he will make a statement on the matter. [9638/02]

A common list of reimbursable medicines was introduced for the general medical services scheme and the drug payment scheme. This list ensures equity between the GMS and DPS in relation to the range of medicines paid for by the State under both schemes. This common list is subject to ongoing review and amendment on a monthly basis as new products become available and deletions are notified.

In order for any item to be included in the common medicines list it must comply with a published list of criteria. These range from their authorisation status where appropriate, their price and in certain cases the uses for which the prod ucts are intended. In addition, the products should ordinarily be supplied to the public only on foot of a medical prescription and should not be advertised or promoted to the public. As the product referred to by the Deputy does not have product authorisation from the Irish Medicines Board it does not qualify for inclusion on the common list of reimbursable medicines.
The Deputy will be pleased to learn that a protocol, a copy of which is included, was drawn up to set out the circumstances and conditions in which a necessary unlicensed medicine may be reimbursed by the State, where lawfully supplied. Applications for reimbursement which meet the circumstances and conditions set out in the protocol should be made to the relevant agency, that is the General Medical Services (Payments) Board or the local health board.
The Deputy will also be pleased to know that a 2.5 mg and 5 mg strength of the product referred to, as well as an elixir form, are included in the common list of reimbursable items.
Top
Share